Filing Details

Accession Number:
0001237899-14-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 16:15:14
Reporting Period:
2014-02-11
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 16:15:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013064 Roy P Vagelos 777 Old Saw Mill River Road
Tarrytown NY 10591
Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-11 11,475 $325.10 103,275 No 4 S Indirect by Spouse as Trustee
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Spouse as Trustee
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 69,960 Direct
Common Stock 1 Indirect by GRAT
Common Stock 2,269 Indirect By 401(k) Plan
Common Stock 158,588 Indirect by CLAT
Common Stock 10,961 Indirect by GRAT
Common Stock 3 Indirect by GRAT
Common Stock 1,203 Indirect by trust for grandch
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 11,475 shares of Company stock on February 11, 2014 at prices ranging from $325.00 to $325.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 11, 2014 at each separate price.
  3. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.